Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular Lymphoma.
follicular lymphoma
immunocompromised patient
obinutuzumab and bendamustine
prolonged COVID-19
Journal
Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241
Informations de publication
Date de publication:
15 Aug 2022
15 Aug 2022
Historique:
pubmed:
2
6
2022
medline:
17
8
2022
entrez:
1
6
2022
Statut:
ppublish
Résumé
A patient with follicular lymphoma treated with obinutuzumab and bendamustine experienced prolonged coronavirus disease-2019 (COVID-19). One month after the symptoms transiently improved, the patient experienced exacerbated COVID-19 symptoms. The patient recovered from COVID-19 with remdesivir and dexamethasone and was discharged 77 days after the disease onset. The patient completed a primary series of SARS-CoV-2 vaccinations on day 176, but the anti-spike protein IgG was not detected later. A careful observation to detect any subsequent relapse of COVID-19 symptoms is necessary in immunocompromised patients. Chemotherapy should be based on the disease status and type of lymphoma.
Identifiants
pubmed: 35650124
doi: 10.2169/internalmedicine.9136-21
pmc: PMC9449615
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
Rituximab
4F4X42SYQ6
Bendamustine Hydrochloride
981Y8SX18M
obinutuzumab
O43472U9X8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2523-2526Références
Hemasphere. 2021 Feb 10;5(3):e538
pubmed: 33604516
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Eur J Cancer. 2021 Apr;147:154-160
pubmed: 33676266
J Infect Chemother. 2021 Feb;27(2):387-389
pubmed: 33328135
Leuk Lymphoma. 2016;57(3):512-9
pubmed: 26696321
Cochrane Database Syst Rev. 2021 Aug 5;8:CD014962
pubmed: 34350582
Nat Commun. 2020 Dec 14;11(1):6385
pubmed: 33318491
J Hematol Oncol. 2021 Oct 14;14(1):168
pubmed: 34649563
J Infect Dis. 2021 May 20;223(9):1522-1527
pubmed: 33556961
Clin Infect Dis. 2021 Apr 26;72(8):1467-1474
pubmed: 33029620
J Infect Dis. 2021 Jan 4;223(1):23-27
pubmed: 33089317
Nat Cancer. 2021 Apr;2(4):392-399
pubmed: 34661163
Am J Hematol. 2021 Aug 1;96(8):934-944
pubmed: 33909916
JAMA Netw Open. 2021 Mar 1;4(3):e213071
pubmed: 33760094